early-stage collaborations across pharmaceutical, medical

2
Boston 42.3601° N, 71.0589° W Early-Stage Collaborations Across Pharmaceutical, Medical Device and Consumer Health Sectors If you are seeking a collaboration or investment to advance your innovative solution to improve human health, make the connection with our Johnson & Johnson Innovation team. Our regional Innovation Centers are located around the globe in the life science hot spots of Shanghai, Boston, South San Francisco and London. Each Innovation Center houses science and technology, dealmaking, and investment experts, offers a range of potential deal structures, and can contribute a variety of resources from across our company, including: - Early-stage research funding - Licensing and collaborations - Investment from seed to later stage private & public financing - Cross-sector expertise - International markets expertise - Pricing and reimbursement - Preclinical, manufacturing and clinical expertise The teams located at the Johnson & Johnson Innovation Center are interested in building relationships with regional entrepreneurs at startup companies, universities and institutes who are developing early-stage innovations that are pre-proof of concept in humans across Pharmaceuticals, Medical Devices and Consumer sectors. Innovation Center Boston (East North America)

Upload: others

Post on 03-May-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Early-Stage Collaborations Across Pharmaceutical, Medical

Boston42.3601° N, 71.0589° W

Early-Stage Collaborations Across Pharmaceutical, Medical Device and Consumer Health Sectors

If you are seeking a collaboration or investment to advance your innovative solution to improve human health, make the connection with our Johnson & Johnson Innovation team. Our regional Innovation Centers are located around the globe in the life science hot spots of Shanghai, Boston, South San Francisco and London. Each Innovation Center houses science and technology, dealmaking, and investment experts, offers a range of potential deal structures, and can contribute a variety of resources from across our company, including:

- Early-stage research funding

- Licensing and collaborations

- Investment from seed to later stage private & public financing

- Cross-sector expertise

- International markets expertise

- Pricing and reimbursement

- Preclinical, manufacturing and clinical expertise

The teams located at the Johnson & Johnson Innovation Center are interested in building relationships with regional entrepreneurs at startup companies, universities and institutes who are developing early-stage innovations that are pre-proof of concept in humans across Pharmaceuticals, Medical Devices and Consumer sectors.

Innovation Center Boston (East North America)

Page 2: Early-Stage Collaborations Across Pharmaceutical, Medical

© Johnson & Johnson Innovation, LLC 2021

Boston Innovation Center Boston (East North America)A regional hub for collaborations throughout Eastern North America255 Main Street, 7th Floor, Cambridge, Massachusetts, 02142T: 617-225-4700

Michal Preminger, Ph.D., MBA, Head, Johnson & Johnson Innovation, East North America

THERAPEUTIC AREA & BUSINESS UNIT SCIENTIFIC LEADS: TRANSACTIONS, NEW VENTURES AND JJDC VENTURE INVESTMENTS:

IMMUNOLOGY Jarrat JordanE: [email protected]

ONCOLOGY

Bob Radinsky E: [email protected]

CARDIOVASCULAR & METABOLISM

Jim Tobin E: [email protected]

NEUROSCIENCE

Eric SchaefferE: [email protected]

INFECTIOUS DISEASES & VACCINES

Nicola La MonicaE: [email protected]

CONSUMER

Stefanie DhandaE: [email protected] MEDICAL DEVICES

Ibraheem BadejoE: [email protected]

DISCOVERY, PRODUCT DEVELOPMENT & SUPPLY

Elena Diez CeciliaE: [email protected]

Gadi Bornstein E: [email protected]

TRANSACTIONS

Jens Bitsch-Norhave E: [email protected]

Lily Cortese E: [email protected]

Colin Moran E: [email protected]

JJDC VENTUREINVESTMENTS

Kadir KadhiresanE: [email protected]

Marian Nakada E: [email protected]

NEW VENTURES

Jennifer Hamilton (Canada)E: [email protected]

Anjali KumarE: [email protected]

Hong XinE: [email protected]

JANUARY 2021